Raines Lab Logo

Phase I Clinical Trial

Drug

QBI-139 (human pancreatic ribonuclease endowed with toxicity for cancer cells)

Goals

  • To evaluate the toxicity and tolerability of QBI-139 in patients with advanced, refractory solid tumors
  • To determine the maximum tolerated dose of QBI-139 in patients with advanced, refractory solid tumors

Sites

  1. MD Anderson Cancer Center
  2. University of Wisconsin Carbone Cancer Center
    (Protocol No. CO08912)